Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 2978
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49742
Hey Squar you know TheBunny over at your main
(2)
smokenhot
10/11/2018 1:43:50 PM
49741
I going to be more than happy to sell those
(1)
Loose Lips
10/11/2018 1:42:54 PM
49740
Let me fix that for you. You meant to write "I
(2)
Drano
10/11/2018 1:35:56 PM
49739
Yeesh....I bought shares at 3.40. Now that's a
Squar
10/11/2018 1:35:04 PM
49738
Those might be some of the shares I bought. My
(2)
Loose Lips
10/11/2018 12:56:11 PM
49737
Daubers it's known we are waiting on BTD
smokenhot
10/11/2018 12:43:59 PM
49736
Agree that we have raised $ and should at least
(2)
zdubble17
10/11/2018 12:43:12 PM
49735
I go agree. Ive now added over 60K shares
(1)
DaubersUP
10/11/2018 12:36:59 PM
49734
DaubersUP even at 16 million shares, that is only
(1)
zdubble17
10/11/2018 12:14:59 PM
49733
Alan. We need a deal or some kind of promising
(1)
DaubersUP
10/11/2018 12:06:00 PM
49732
Volume was around 500k but has flatlined for
Drano
10/11/2018 11:39:30 AM
49731
At 11:30 or two hours into the trading day volume
AlanC
10/11/2018 11:33:54 AM
49730
I would buy the .17's and consider yourself
(3)
AlanC
10/11/2018 9:57:08 AM
49729
The financing deal put my solvency concerns to
(1)
Squar
10/11/2018 9:53:55 AM
49728
Convinced me to pick up a bit more here Zdub.
Squar
10/11/2018 9:51:30 AM
49727
Good point. I have always felt that as painful as
(4)
Loose Lips
10/11/2018 9:50:53 AM
49726
It is what it is.
Kelt
10/11/2018 9:16:58 AM
49725
Sub penny thoughts are a bunch of nonsense. That
scgmck1
10/11/2018 8:59:45 AM
49724
I think what cracks me up is that this company
(11)
zdubble17
10/11/2018 8:50:52 AM
49723
yeah that will show the crooks. I got my sub
(2)
Jimmyboy
10/11/2018 8:49:04 AM
49722
If they are foolish enough do that, they will
(2)
scgmck1
10/11/2018 8:36:33 AM
49721
Really? Squar don't show your motive that easy.
zdubble17
10/11/2018 8:28:11 AM
49720
Anyone have a guess on trading? Are 0.17s the buy
(2)
Squar
10/11/2018 7:58:02 AM
49719
Priority review accompanying BTD for B-OM - yes.
(1)
Squar
10/10/2018 10:13:29 PM
49718
Included in it is "Material threat medical
(1)
Squar
10/10/2018 10:08:50 PM
49717
DaubersUp in the Swamp had a good post. Yes there
(6)
Trading Pro Broker
10/10/2018 8:55:06 PM
49716
Priority Review could/would be used in the
Kelt
10/10/2018 8:49:09 PM
49715
This is the list of criteria for a drug to meet
(2)
Kelt
10/10/2018 8:43:51 PM
49714
42% marked today and this does not include the
(1)
AlanC
10/10/2018 5:46:54 PM
49713
PRV is usually awarded for Orphan Drug
(1)
Squar
10/10/2018 5:35:10 PM
49712
IPIX pre market (t trades) today .. 09:29:22 0.20
(2)
4kids
10/10/2018 5:22:28 PM
49711
That is what I think as well.
Trading Pro Broker
10/10/2018 4:12:43 PM
49710
Another thought is that in order to secure the
(4)
Kelt
10/10/2018 4:10:09 PM
49709
Another good resource regarding PRV.
scgmck1
10/10/2018 3:31:49 PM
49708
"When seeking approval for a drug, manufacturers
(1)
Drano
10/10/2018 2:06:25 PM
49707
Drano,DoubleJ123 or any long term member here
(3)
Kelt
10/10/2018 1:58:10 PM
49706
I bet BTD was submitted when term sheet was
(4)
smokenhot
10/10/2018 1:54:09 PM
49705
The FDA will respond in 14 days for Type B (EOP)
(4)
sox0407
10/10/2018 1:49:56 PM
49704
The way the market loks some would think the sky
(3)
BooDog
10/10/2018 1:36:19 PM
49702
Trading just dried up. No trades for quite a
Drano
10/10/2018 1:06:08 PM
49701
With the position you're amassing in IPIX, pretty
Drano
10/10/2018 12:48:05 PM
49700
One thing I have noticed is that Leo and Art just
(4)
Chemdeps
10/10/2018 12:34:05 PM
49699
Very well could be Alan. Certainly putting the
(1)
BooDog
10/10/2018 12:17:12 PM
49698
That's a good point. It could be that someone is
(2)
Drano
10/10/2018 12:03:50 PM
49697
I just want to speculate a bit...maybe this
(3)
doubleJ23
10/10/2018 12:00:49 PM
49696
I think Leo is working a carefully crafted plan
(4)
AlanC
10/10/2018 11:53:03 AM
49695
We know the "Level 2" is not accurate. But
(2)
Drano
10/10/2018 11:48:00 AM
49694
Here's the Edgar (gov) link directly to the 8-K
Drano
10/10/2018 11:39:32 AM
49693
That sounds right to me. I have to think Co.
doubleJ23
10/10/2018 11:31:47 AM
49692
I bet our new partner will be sitting at that
(2)
smokenhot
10/10/2018 11:20:36 AM
Newer
Older
Recent Articles
Neuronetics Welcomes Steven Pfanstiel as CFO—A New Era Begins
S&P Global Partners with Anthropic to Transform Financial Analysis
SELLAS Advances SLS009 for First-Line AML Following Phase 2 Success
Maryland Court Decision Strengthens MSP Recovery's Case Against GEICO
Transformational Leadership Change at Neuronetics Strengthens Vision
Emergent BioSolutions Sets Date for Q2 Financial Call
Plus Therapeutics Advances with REYOBIQ™ in Clinical Trial Results
Iovance Biotherapeutics Enhances Leadership with CFO Appointment
WestKam Gold Corp. Welcomes New Interim CFO and Funding Initiative
Changes to Synthetic Dyes in Ice Cream: Major Industry Impact
ProKidney and FDA Collaboration on Rilparencel Approval Insights
Mark Cuban Spotlights Political Strategies of Zohran Mamdani
Unlock Profits with AAS MINER's Smart Mining Innovation
BriaCell Expands Cancer Research Collaborations with Mayo Clinic
Abeona Therapeutics Expands Access to ZEVASKYN Gene Therapy
Mill Creek Residential Opens Modera St. Paul for New Residents
Nexxen Expands CTV Opportunities Through Partnership with VIDAA
Alidade Capital Expands Leadership in Net Lease Investments
Emergent BioSolutions Plans Q2 Financial Reporting Events
Rhode Island's New Law Shields Homeowners from Bad Contracts
Iovance Biotherapeutics Welcomes Corleen Roche as CFO
Insights on Trade Desk Inc and Other Market Movers Today
Sky Quarry Embarks on Innovative Digital Asset Strategy
Canada Nickel Unveils Promising Mineral Resource Estimates
Westgate Energy's Strategic Advances in Oil Production and Market Growth
Spectral Capital Expands Portfolio with 42 Telecom Acquisition
GIBO Holdings Innovates Monetization for Short-Drama Platforms
Palatin Advances Obesity Research with PL7737: Key Findings
Exciting New Bybit Promotion Offers 20,000 USDT Weekly Rewards
BlackRock Sees Significant Revenue Growth and AUM Increase
Innovative Partnership to Enhance Marine Retail Solutions
Breakthrough Advances in Weight Loss Solutions by Palatin
Western Copper and Gold's Essential ESE Project Update
Coveo's Strategic Moves: Renewing Your Investment Confidence
OSR Holdings Welcomes Dr. Niethammer as New CMO of Vaximm
PSEG To Share Insights on Q2 2025 Financial Performance
GIBO Click Achieves Milestone with DramaFlow Monetization Engine
Freightos Achieves Record Performance in Second Quarter
7-Eleven Unveils Flavorful New Menu for Summer Enjoyment
Mokas Coffee & Eatery Announces Exciting Franchise Plans
Rhode Island's New Law Shields Homebuyers from Unfair Practices
S&P Global and Anthropic Collaborate to Transform Financial Data Access
Eshbal Expands U.S. Market Reach with Strategic Moves
YMCA's Ongoing Recovery Empowered by Community Support
Navigating Uncertain Markets: Insights from M4Markets Podcast
Aurora Spine Engages at Prestigious Pain Management Conference
Maryland Court Victory Boosts MSP Recovery's Legal Efforts
Acumen Pharmaceuticals Partners with JCR for Alzheimer’s Therapy Development
Goodfood Market Corp to Announce Q3 Fiscal 2025 Results Soon
Flagship Communities REIT Declares July 2025 Cash Distribution